Date: May 2, 2006
Contacts: Bill Kearney, Director of Media Relations
Megan Petty, Media Relations Assistant
Office of News and Public Information
202-334-2138; e-mail <>


New Committee Will Provide Updates to Stem Cell Research Guidelines;
Scientists and Others Invited to Comment On Use of Guidelines

WASHINGTON -- The National Academies' National Research Council and Institute of Medicine today announced the appointment of a committee to monitor and revise voluntary guidelines on the conduct of human embryonic stem cell research. The committee -- the creation of which was encouraged by numerous scientific organizations, research institutions, and individual scientists -- will provide updates to the voluntary guidelines issued last year by the Academies. The updates will be issued in periodic reports.

The Research Council and IOM also today encouraged researchers and others to comment on the usefulness of the 2005 guidelines and whether they need to be updated to reflect new scientific findings, public policies, and legal rulings, as well as evolving ethical issues. Comments can be submitted at, where more information on the new committee is available, along with a free PDF file of last year's Guidelines for Human Embryonic Stem Cell Research. Workshops also will be held to keep the committee informed of developments in the field.

The committee's work will be supported by The Ellison Medical Foundation, The Greenwall Foundation, and the Howard Hughes Medical Institute. There is a 20-day public comment period on the makeup of the committee, which will remain provisional until it is fully vetted. Reports written by the committee will undergo external peer review prior to public release.

The National Research Council and Institute of Medicine are private, nonprofit institutions that provide science, technology, and health policy advice under a congressional charter. A roster of the new committee follows.

[ This news release is available at ]

Division on Earth and Life Studies
Board on Life Sciences
Board on Health Sciences Policy

Human Embryonic Stem Cell Research Advisory Committee

R. Alta Charo, J.D. (co-chair)
Warren P. Knowles Professor of Law and Bioethics
University of Wisconsin Law School and Medical School, and
Visiting Professor of Law
Boalt Hall School of Law
University of California

Richard O. Hynes, Ph.D.
Howard Hughes Medical Institute, and
Daniel K. Ludwig Professor for Cancer Research
Center for Cancer Research and Department of Biology
Massachusetts Institute of Technology

Eli Y. Adashi, M.D., M.S.
Dean of Medicine and Biological Sciences
Brown University
Providence, R.I.

Brigid L.M. Hogan, Ph.D.
George Barth Geller Professor and Chair
Department of Cell Biology
Duke University Medical Center
Durham, N.C.

Marcia Imbrescia, B.A.
Owner, Peartree Design, and
Member, Board of Trustees
Arthritis Foundation
Lynnfield, Mass.

Terry Magnuson, Ph.D.
Sarah Graham Kenan Professor and Chair
Department of Genetics
University of North Carolina;
Director, Carolina Center for Genome Sciences; and
Director of Cancer Genetics
Lineberger Comprehensive Cancer Center
Chapel Hill

Linda B. Miller, O.T.R., M.S.
Volunteer Trustees Foundation
Washington, D.C.

Jonathan D. Moreno, Ph.D.
Emily Davie and Joseph S. Kornfeld Professor of Biomedical Ethics, and
Center for Biomedical Ethics
University of Virginia

Stuart H. Orkin, M.D.
Howard Hughes Medical Institute;
David G. Nathan Professor of Pediatrics
Harvard Medical School; and
Chair, Department of Pediatric Oncology
Dana-Farber Cancer Institute

Pilar N. Ossorio, Ph.D., J.D.
Associate Professor of Law and Bioethics
University of Wisconsin Law School
Madison, and
Visiting Professor of Law
Boalt Hall School of Law
University of California

E. Albert Reece, M.D., Ph.D.
Vice Chancellor and Dean
University of Arkansas for Medical Sciences
Little Rock

Joshua R. Sanes, Ph.D.
Professor of Molecular and Cellular Biology, and
Paul J. Finnegan Family Director of the Center for Brain Science
Harvard University
Cambridge, Mass.

Harold T. Shapiro, Ph.D.
President Emeritus, and
Professor of Economics and Public Affairs
Woodrow Wilson School of Public and International Affairs
Princeton University
Princeton, N.J.

John E. Wagner Jr., M.D.
Professor of Pediatrics
Medical School, and
Scientific Director of Clinical Research
Stem Cell Institute
University of Minnesota


Adam P. Fagen
Study Co-Director

Bruce Altevogt
Study Co-Director

Fran Sharples
Director, Board on Life Sciences

Andrew Pope
Director, Board on Health Sciences